fig1

Figure 1. Main approach for the assessment of cardiovascular risk in individuals with MASLD. Current data are insufficient to recommend a specific risk calculator in MASLD, and the choice should be made based on the population (e.g., North America vs. Europe) and local guidelines. Created in BioRender. Arab, J. (2025) https://BioRender.com/ihth6bo. MASLD: Metabolic dysfunction-associated steatotic liver disease; ACC: American College of Cardiology; AHA: American Heart Association; HDL: high-density lipoprotein; SCORE2: Systematic Coronary Risk Estimation 2; SCORE2-OP: Systematic Coronary Risk Estimation 2–Older Persons; CVD: cardiovascular disease; CAC: coronary artery calcium; Lp(a): lipoprotein(a); hs-CRP: high-sensitivity C-reactive protein.